Research

Limit: 1  // PI: V. Kamath (Basic Medical Sciences)


The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions.To be eligible, PI must be a full-time Assistant or Associate Professor working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. Each total grant is limited to $80,000 (direct costs) for a two year grant period. Funding is to be directed at pilot research projects that are both innovative and will likely lead to successful grant applications to NIH and other public and private funding entities.

Eligibility
To be eligible, PI must be a full-time Assistant or Associate Professor at an invited US academic institution, working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. The grant proposal must detail a new research project that is not funded by other sources. This grant is not to be used as bridge funding.

Investigators at institutions that are affiliated with a medical school or university are eligible to apply only through the institution where they hold a full-time faculty position.

Scientists that have previously received a BRF Seed Grant may not receive the award for a second time unless all grant requirements from all previous awards are met. Only one PI may apply per application.

Limit: 2  // PIs: 
Kenry (Pharmaceutics & Pharmacokinetics)
S. Song (Biomedical Engineering)

Only two nominations are allowed per institution.

These competitive research awards provide seed money for junior faculty members that often result in additional funding from other sources. The award amount provided by ORAU is $5,000. The applicant’s institution is required to match the award with at least an additional $5,000. This is a one-year grant (June 1 to May 31).

Eligibility for the Powe Awards is open to full-time assistant professors at ORAU member institutions within two years of their tenure track appointment at the time of application. If there is a question about eligibility, your ORAU Councilor makes the final determination. Only two nominations are allowed per institution.

Research projects must fall within one of these five disciplines:

• Engineering and Applied Science
• Life Sciences
• Mathematics/Computer Sciences
• Physical Sciences
• Policy, Management, or Education

Junior faculty members interested in applying should consult their ORAU Councilor, and visit the frequently asked questions.

 The University of Arizona Cancer Center (UACC) coordinates the selection process for this limited submission opportunity. For more information, please contact: UACC-PreAward@arizona.edu 

UACC Limited Submission Information:

The University of Arizona Cancer Center (UACC) can nominate one application for the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) for FY2024.

Purpose of Award:

The UACC is seeking nominations for an NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) which is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers.

This Notice of Funding Opportunity (NOFO) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Applicant Eligibility:

• Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.
• An applicant must be a citizen or a noncitizen national of the United States, or has been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen with a valid U.S. visa. For applications submitted on behalf of non-U.S. citizens with valid U.S. visas, the visa status during each phase of the F99/K00 award must allow the PD/PI to conduct the proposed research at the applicant institution. For the F99 phase of the award, the applicant F99 institution is responsible for determining and documenting, in the nomination letter, that the applicant's visa will allow the applicant to remain in the U.S. to complete the F99 phase of the award, and that there are no known obstacles that would prevent the applicant from obtaining a visa for the K00 phase. For the K00 phase of the award, the U.S institution at which the K00 phase of the award will be conducted is responsible for determining and documenting, in the transition application, that the PD/PI’s visa will allow the PD/PI to remain in the U.S. for the duration of the K00 award. NCI may request verifying information as part of the pre-award process.
• The applicant must have a baccalaureate degree and be currently enrolled as a graduate student in the third or fourth year of a mentored PhD or equivalent research degree program (e.g., DrPH, ScD) in the biomedical, behavioral, or clinical sciences at a domestic institution. F99 eligibility is determined from the date of enrollment as a graduate student at the PhD institution and includes the time spent to earn a MS degree unless there was a major change in research area and a change in research mentor. The applicant must be at the dissertation research stage of training at the time of award, and must show evidence of high academic performance in the sciences and commitment to a career as an independent cancer research scientist.
• This program is expected to enhance the research career trajectories of cancer researchers and foster progression to research independence. K00 awardees remain eligible to apply to subsequent mentored Career Development (K) and Pathway to Independence (K99/R00) award programs.
• The F99/K00 award may not be used to support studies leading to the MD, DDS, or other clinical, health-professional degree (e.g., DC, DMD, DNP, DO, DPM, DVM, ND, OD, AuD). Students matriculated in a dual-degree program (e.g. MD/PhD, DO/PhD, DDS/PhD, or DVM/PhD) are not eligible for the F99/K00 program.

N. Kitamura on behafh J.Galligan's Lab (Pharmacology and Toxicology)
K. Rahman on behafh H. Li's Lab (Pharmacology and Toxicology)

Only one postdoctoral applicant per lab may apply for this award.

Successful drug discovery involves the innovative application and integration of multiple scientific disciplines to create efficacious, safe, and differentiated treatment options for patients. The PhRMA Foundation seeks to fund novel early-stage, exploratory drug discovery research with the potential for translation to humans, including biological validation of potential drug targets, signaling pathways, or mechanisms of disease.  

Research topics could include, but are not limited to:   

• Genomics and Proteomics  
• Cellular and Molecular Biology  
• Design and Generation of Pharmacological Tools   
• In Vitro and/or In Vivo Pharmacology  
• Protein Biochemistry  
• Molecular Modelling  
• Structural Biology  
• Cell Imaging  
• Single Cell Analysis  
• Artificial Intelligence and Computational Approaches  

Projects that focus exclusively on single aspects such as identification of and development of assays for single targets, chemical probes, biomarkers, chemical library screening, or diagnostics will not be considered for review. Project aims should have a high likelihood of completion in the award timeframe

No applicants  // Limit: 1 // Tickets Available: 1 

This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.

Limit: 2  // PIs: 
H. W .Tseng (College of Medicine Tucson -Medical Imaging) 
X. Yan (Materials Science) 

The Moore Inventor Fellows fellowship focuses on supporting scientist-inventors at a critical prototyping stage to capture opportunities that otherwise might be missed. We seek to provide freedom and support to promising inventors with the most compelling ideas to pursue creative and disruptive innovations.

The scope of this call is intentionally wide: proposed projects do not need to fall within our current funding priorities but should be broadly within the program areas of foundation interest (science, environmental conservation and patient care). Patient care inventions should resonate with our focus on improving the experience and outcomes of patients with solutions that improve clinical diagnosis.

Eligibility: Candidates must be faculty, research scientists, postdocs or other full-time staff who can receive funding through their institutions. Candidates must be no more than 10 years past receiving their terminal advanced degree in their field (M.S., Ph.D. or M.D.) Please see the Moore Inventor Fellows FAQ for more information regarding candidate eligibility and exceptions.

Funding: Fellows will receive funding for three years at a level of $200,000 per year from the Moore Foundation. In addition to funds for the fellow, the foundation will provide $25,000 each year to the institution to cover costs associated with administering the grant award, resulting in a total three-year award of $675,000. Host institutions are required to contribute $50,000 in annual support of the inventor’s work

 Limit: 1  // PI selected:  J. Rainbow ( College of Nursing) - Competitive Resubmission 

The Betty Irene Moore Fellowship for Nurse Leaders and Innovators program is led by the Betty Irene Moore School of Nursing. The nationally ranked UC Davis Graduate School of Management partners with us to provide expertise in leadership, innovation and entrepreneurship. This highly synergistic partnership across schools focuses on preparing the next generation of leaders who are inspired and committed to make a positive impact.

A $37.5 million award from the Gordon and Betty Moore Foundation funds the program. One of the foundation’s early investments was the Betty Irene Moore School of Nursing at UC Davis. With this new school, the foundation sought to advance health and ignite leadership through innovative education, transformative research and bold system change. The fellowship program builds on that vision, and with the UC Davis Graduate School of Management, offers a dynamic opportunity for development in leadership and innovation.

Limit: 1  // PI selected:  M. Eichenfield (Optical Sciences)

Number of applications allowed per institution: 1

The NSF is introducing the National Quantum Virtual Laboratory (NQVL) concept as an overarching shared infrastructure designed to facilitate the translation from basic science and engineering to the resultant technology, while at the same time emphasizing and advancing its scientific and technical value. The NQVL aims to develop and utilize use-inspired and application-oriented quantum technologies. In the process, NQVL researchers will explore quantum frontiers, foster Quantum Information Science and Engineering (QISE) workforce education and training, engage in outreach activities at all levels, and promote broadening participation, diversity, equity, and inclusion in QISE, thereby lowering barriers at all entry points of the research enterprise.

The engagement of the entire United States (U.S.) QISE community will be necessary for this initiative to succeed, and, indeed, the project is designed to include participation from a full spectrum of organizations who have expertise to contribute. In particular, NSF recognizes that the involvement of industry partners is essential and will welcome these to be a part of the overall structure. Partnerships with other U.S. Federal agencies under the NQI umbrella are also encouraged.

This solicitation lays out a vision for the entire NQVL program that includes Quantum Science and Technology Demonstration (QSTD) projects, support for enabling technologies through Transformative Advances in Quantum Systems (TAQS), as well as a central coordination hub. Proposals for Pilot phase QSTDs are solicited at this time.

This opportunity is for Pilot phase QSTD proposals only.
QSTD Pilot awards may be funded at a level up to $1,000,000 for 12 months per project.

S. Hamilton (Cellular and Molecular Medicine)

UArizona may submit one application.

Program Focus and Overview: The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of the prevention of coronary heart disease or circulatory failure, and improving care for these patients. The Program focuses on basic and translational scientific research. Clinical studies are currently ineligible.

In accordance with Mr. Geneen’s directives the Program supports smaller, mid-sized institutions “rather than major universities or medical complexes which have a demonstrated capacity to raise funds from the public generally.”

Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply.

Eligibility: Each invited institution may submit a single application from a full-time faculty member. United States citizenship is not required. Junior faculty and those with less than $500,000 in direct costs funding at the time of application are encouraged to apply.

M. Dodson ( Pharmacy)

UArizona is allowed a maximum of one nomination per grant cycle to one of the Pathway Program Award types: Initiator or Accelerator.

Pathway to Stop Diabetes has a simple, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. We attract and retain brilliant scientists in diabetes. Our three areas of focus—awarding research grants, providing access to scientific and career mentoring from leading diabetes researchers, and creating a diabetes think tank—are each key components of a unique formula to cultivate the next generation of leaders, whose discoveries will stop diabetes and all of its burdens once and for all.

Initiator Award (INI)

• Award Term: Up to 7 years
• Applicant: Postdoctoral Fellow
• Maximum Funding: Up to $100,000/year in Phase 1, Up to $325,000/year in Phase 2
• Support: Project support & PI salary
• Indirect Support: Up to 10% of directs in Phase 1, Up to 30% of directs in Phase 2
• Project % Effort Required: 75-100% effort in Phase 1, 50-75% effort in Phase 2
• Citizenship: Authorized to work in U.S. or U.S. possessions
• Description: This two-phased award is designed to support the transition of scientists from mentored training to independent research faculty.
• Eligibility: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
• Support: Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.

Accelerator Award (ACE)
 

• Award Term: Up to 5 years
• Applicant: Early Career Faculty
• Maximum Funding: $325,000/year
• Support: Project support & PI salary
• Indirect Support: Up to 30% of directs
• Project % Effort Required: 25-50% effort
• Citizenship: Authorized to work in U.S. or U.S. possessions
• Description: This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.
• Eligibility: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
• Support: Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.